Effectiveness of Cervical Transforaminal Epidural Steroid Injection

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

October 31, 2022

Study Completion Date

December 7, 2023

Conditions
Cervical RadiculopathyCervical SpondylosisDisk, Herniated
Interventions
DRUG

Cervical Transforaminal Epidural Injection with dexamethasone sodium phosphate

Transforaminal epidural steroid injection: Injection of 1 to 2 mL of 1% lidocaine to the skin and subcutaneous tissues, a 25-gauge spinal needle will be placed at the level and side of radicular pathology, based on clinical correlation of symptoms/signs and magnetic resonance imaging findings. Advancement to the appropriate target position in the neuroforamen will be performed under fluoroscopic guidance. Satisfactory target position achieved and confirmed in both anterior-posterior and oblique views, 0.5 to 1 mL of contrast will be injected under live fluoroscopic observation with or without digital subtraction angiography depending on suggestion of vascular uptake. Upon confirmation of a satisfactory epidural contrast pattern without vascular uptake, the injectate will be delivered: dexamethasone sodium phosphate 1mL (10mg/mL) and 0.5 ml of 1% preservative-free lidocaine (total volume 1.5 mL).

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04544683 - Effectiveness of Cervical Transforaminal Epidural Steroid Injection | Biotech Hunter | Biotech Hunter